NasdaqGM:ARDXBiotechs
A Look At Ardelyx (ARDX) Valuation After Strong Q1 Results And Updated 2026 Guidance
Ardelyx (ARDX) just reported first quarter 2026 results, with revenue of US$94.47 million versus US$74.11 million a year earlier, a net loss of US$37.61 million and a loss per share of US$0.15.
See our latest analysis for Ardelyx.
The latest earnings update, management commentary and new Chief Legal Officer appointment appear to be feeding into fresh interest in the stock. A 1-day share price return of 8.69% and a 1-year total shareholder return of 66.59% indicate positive but recently...